Skip to content
Navigate to homepage - Cerba Research

Case Study – Phase 2 To Determine Safety And Efficacy Of A mAB CKI Combo In Relapse Refractory Multiple Myeloma (RRMM)

Discover how we managed cell isolation and counts among other routine and speciality tests for a large Relapse Refractory Multiple Myeloma  study over 11,000 samples managed.

Tests including FCM, PBMC isolation and count, FISH

Reach out to our experts and discover how we can help you advance your clinical trial